Impact of the Biofield Energy Treated Proprietary Novel Formulation on Memory and Cognition Function in Neuronal Cell

Impact of the Biofield Energy Treated Proprietary Novel Formulation on Memory and Cognition Function in Neuronal Cell

Health & Well-being, Preclinical Research

The current study was investigated for the in vitro cognitive effect of the Consciousness Energy Healing (The Trivedi Effect®) Treated novel proprietary test formulation in terms of acetylcholinesterase (AChE) inhibition, neuroprotection, and neurite outgrowth assays in two different neuronal cell-lines (SHS-Y5Y and PC-12 Cells). The test formulation divided into two parts; one part was received the Biofield Energy Treatment by Mr. Mahendra Kumar Trivedi and termed as the Biofield Energy Treated sample, while the other part was denoted as the untreated test sample. Cell viability using MTT assay in SHS-Y5Y and PC-12 cells showed more than 83% cells were viable upto 10.41 μg/mL of the tested concentrations, indicating that the test formulation was safe and nontoxic. The inhibition of AChE enzyme activity was observed by 2.9% in the Biofield Energy Treated test formulation group at 5 μg/mL compared to the untreated test formulation group. The Biofield Energy Treated test formulation group exhibited by 54.83%, 61.37%, 21.51%, and 20.48% cell viability (in terms of restoration of neural protection) at the concentrations of 0.007, 0.013, 0.052, and 0.104 μg/mL, respectively compared to the MPP+ group. Moreover, the Biofield Energy Treated test formulation showed 48.07% and 36.54% inhibition of Catechol-O-methyl transferase (COMT) enzyme activity at 0.03 and 0.05 μg/mL, respectively compared to the MPP+ group. The Biofield Energy Treated test formulation also exhibited 166.67%, 250%, 250%, and 20% increased numbers of differentiating neurite cells at 0.03, 0.05, 0.1, and 1.04 μg/mL, respectively compared to the untreated test formulation group. In summary, the Biofield Energy Treated test formulation significantly inhibited AChE and COMT enzymes activities which can improve the memory and cognition function by increasing cell to cell communication, neuronal protection, and neuronal outgrowth. These data indicated that the Biofield Energy Treated novel proprietary formulation has the potential beneficial effects for Neurodegenerative disorders, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease, that affect millions of people around the world.

Trivedi MK and Jana S

Annex Publishers

December 19, 2019

[no text]

[no text]

[no text]

[no text]

English

Journal Article

[no text]

[no text]